Want to join the conversation?
For 4Q15, $BXLT expects adjusted earnings, excluding special items, of $0.55-0.57 per diluted share. Excluding the impact of FX, $BXLT anticipates pro forma sales growth of 3-5% and including the impact of FX, pro forma sales to decline 1-3%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?